Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.
Press releases published on April 29, 2025
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
GlobeNewswire
·
April 29, 2025
Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device Designations The Virtue Trial will be …
Annovis Bio Appoints Hui Liu as Director of Biostatistics
GlobeNewswire
·
April 29, 2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) …
Clean Earth Introduces Enhanced Regulatory Compliance Services
GlobeNewswire
·
April 29, 2025
Comprehensive regulatory compliance service packages include reporting, auditing, and training Services are offered to Clean Earth customers across multiple industries KING OF PRUSSIA, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Clean Earth, a division of …
Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress
GlobeNewswire
·
April 29, 2025
CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six …
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
GlobeNewswire
·
April 29, 2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene …
Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
GlobeNewswire
·
April 29, 2025
WAYNE, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that Jesse Hall, M.D. has …
First Commonwealth Announces First Quarter 2025 Earnings; Increases Quarterly Dividend
GlobeNewswire
·
April 29, 2025
INDIANA, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- First Commonwealth Financial Corporation (NYSE: FCF) today announced financial results for the first quarter of 2025. Financial Summary (dollars in thousands, For the Three Months Ended except per share data …